A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects
Clinical trial NCT06744868 · COMPLETED
Trial details
- NCT number
- NCT06744868
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2024-09-22
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.